Navigation Links
Preventice Expands Options for Wireless Patient Monitoring with Qualcomm Life
Date:5/24/2012

MINNEAPOLIS, May 24, 2012 /PRNewswire/ -- Preventice, Inc., a developer of mobile health applications and patient monitoring systems, announced today that it is the latest to join medical device manufacturers, application developers, health care services companies and payors that are integrating with Qualcomm Life Inc., a wholly owned subsidiary of Qualcomm Incorporated, and their 2net™ Ecosystem.

(Logo: http://photos.prnewswire.com/prnh/20120417/CG89172LOGO)

Preventice is a break-through developer of mobile health applications with an emphasis on remote patient monitoring systems that deliver continuous care. Preventice's cutting-edge solutions allow individuals to remain active and independent while their individual physiologic characteristics are being monitored with a simple and discreet body-worn sensor. Preventice will leverage Qualcomm Life's 2net Platform in order to provide chronic care patients with multiple remote connectivity options.

"Our work with Qualcomm Life supports the Preventice mobile health strategy that focuses on maintaining the critical physician-patient connection," said Jon Otterstatter, co-founder, president and CEO of Preventice. "The Preventice remote monitoring solutions together with the 2net Hub connectivity will not only allow providers to cost-effectively assess their patients' health and behaviors at any time, but it will further facilitate the secure data collection, transport and analysis essential to driving better health care outcomes and lowering costs."

Qualcomm Life's 2net Platform and Hub connects wireless medical devices via cloud-based solutions so that biometric information is easily accessible by device users, their health care providers and caregivers. The 2net Platform and Hub are intended to transfer, store, convert and display medical device data.

"The ability to store comprehensive patient data is an integral part of building mobile health applications and remote patient monitoring systems," said Rick Valencia, vice president and general manager of Qualcomm Life. "We are looking forward to working with Preventice to enhance connectivity and responsiveness of their offerings."

About Preventice

Preventice is a privately owned company and leading developer of mobile health applications and remote monitoring systems that connect mobile, home-based, and on-premise technologies to deliver continuous patient care across the health continuum—wherever an individual patient might be. Applications from Preventice create a constant connection and exchange of data between health care providers, life science companies and their patients. Current applications from Preventice address high-cost conditions and health management opportunities, including prescription medication management, cardiac care, sleep apnea, diabetes management, and migraine headaches. Preventice is headquartered in Minneapolis, with offices in Rochester, Minn., and Fargo, N.D. For more information, visit www.preventice.com.

Qualcomm is a registered trademark of Qualcomm Incorporated. 2net is a trademark of Qualcomm Incorporated. All other trademarks are the property of their respective owners.

For more information:

Colleen Kulhanek
+1-651-307-9486
Preventice

Barbara Tabor, APR
+1-651-230-9192
Tabor Communications Consulting for Preventice


'/>"/>
SOURCE Preventice
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. National Science Foundation grant expands UMCES oyster research
2. Research-based undergraduate course expands beyond Washington University
3. UNC expands brain imaging study of infants at risk for autism
4. Stowers Institutes Linheng Li Lab expands understanding of bone marrow stem cell niche
5. Springer expands its portfolio in plant sciences with Phytoparasitica
6. SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog
7. New book expands field data available on orangutans
8. Fetal alcohol syndrome testing expands
9. NIH expands Human Microbiome Project; funds sequencing centers and disease projects
10. Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line
11. ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: